Published by Coherent Market Insights
Posted on September 29, 2021
5 min readLast updated: February 1, 2026
The Generic Drugs Market is set for exponential growth by 2027, driven by chronic diseases and market dynamics influenced by COVID-19.
The Generic Drugs Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2021-2027). The research presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data.
Generic Drugs Market report presents the detail analysis of the parent market based on elite players, present, past and futuristic data which will serve as a profitable guide for all the industry competitors. Key players in the Generic Drugs market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All measurement shares, splits, and breakdowns have been resolute using secondary sources and verified primary sources. The Market report begins with a basic overview of the industry lifecycle, definitions, classifications, applications, and industry chain structure and all these together will help leading players understand scope of the Market, what characteristics it offers and how it will fulfill customer’s requirements.
Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1084
Generic drugs are those that have the identical active chemical substance as that of a patented drug. Before generics became available, generic drugs were manufactured by using identical active ingredients, with the only difference being the chemical composition or dosage. Generic drugs can be sold without any authorization from the Food and Drug Administration. Generic drugs can also be made and approved at the same time as the patented drug if the company that holds the patent for the medicine can meet the necessary requirements. Once these requirements are met, a generic drug can be released into the market. Generic drugs, however, are not available without a prescription from a doctor, because generic drugs lack the security provided by patented drugs.
Key Market Drivers:
Increasing cases of chronic diseases in the world are the main factor that is expected to drive the growth of the global generic drugs market. For instance, according to World Health Organization, around 422 million individuals in the world suffer from diabetes and around 1.6 million deaths are directly related to diabetes every year. Generic drugs are manufactured using the same facilities and methods as patented drugs. In fact, they are typically the same product created with the same quality and consistency. However, generic drugs are made so that they can meet or surpass the safety and efficacy requirements of the U.S. Food and Drug Administration. Generic drugs can be sold without the need for an expensive marketing campaign because generic drugs can be made for lower prices than patented drugs. Increasing product launches by key market players are estimated to propel the growth of the global generic drugs market.
Covid-19 Impact Analysis:
The increasing incidence of COVID-positive cases in the world has majorly affected the growth of the global generic drugs market. For instance, according to Springer, in April 2020, the number of individuals infected with the SARS-CoV-2 was around 0.9 million with a death ratio of around 1.38%. Moreover, increasing transport restrictions and lockdown restrictions in several nations also affected the market growth.
Key Takeaways:
The size of the global generic drugs market was assessed at around US$ 263 billion in 2020 and at a CAGR of 6.58% is estimated to reach around US$ 385 billion in the year 2026, owing to increasing chronic diseases in the world. For instance, according to International Agency for Research on Cancer, in 2020 the global burden of cancer was around 19.3 million.
North America is expected to hold a major share of the global generic drugs market, owing to the increasing prevalence of drug manufacturers in the region. For instance, according to Pharmapproach, in 2019, the United States generated a revenue of around US$ 490 billion.
The Asia Pacific is expected to witness high growth in the global generic drugs market, owing to the increasing prevalence of pharma companies in the developing regions. For instance, according to India Briefing, there are more than 3000 drug companies in India, along with 10,500 manufacturing units.
What Generic Drugs Market report offers:
Major Players Analysed The Market
These Players Are: Teva Pharmaceutical Industries, Mylan N.V., Novartis International AG, Pfizer, Inc., Allergan Plc, Sun Pharmaceuticals, Fresenius Kabi, Sanofi, Endo International, Lupin Ltd., Abbott Healthcare, AstraZeneca Plc, and Novo Nordisk.
Remarkable Attributes of Generic Drugs Market Report:
Buy This Research Study Report For Quick Access with flat US $ 2000 off@ https://www.coherentmarketinsights.com/promo/buynow/1084
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
The post Exponential Growth Expected for Generic Drugs Market with Complete SWOT Analysis by Forecast to 2021 to 2027 appeared first on Gatorledger.
The article focuses on the growth and analysis of the Generic Drugs Market from 2021 to 2027.
COVID-19 has affected market growth due to increased cases and restrictions.
Increasing chronic diseases and product launches are key growth drivers.
Explore more articles in the Research Reports category
